AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication.

Authors

Artem Krokhin, Julia Romanova, Regina Grillari, Matthias Hackl, Pavel Korabliov, Jozef Mandík, Andrej Egorov

Published in

Vaccine. Volume 94. Pages 129237. Oct 18, 2026. Epub Oct 18, 2026.

Abstract

Continuous cell substrates with improved permissiveness for influenza virus replication are of considerable interest for vaccine development and manufacturing. Vero cells have an excellent regulatory track record; however, their relatively low influenza virus productivity limits their broader application.
We developed the AEX-1 cell line by co-cultivating Vero cells with chicken embryo amniotic membrane fragments. Cellular morphology, intracellular acidification, influenza virus replication, transcriptomic profile, genetic stability, and tumorigenicity were evaluated.
AEX-1 cells displayed distinct morphology and enhanced endosomal/lysosomal acidification compared with parental Vero cells. At 72 h post-infection, a commonly used harvest time for influenza vaccine virus production, AEX-1 cells produced higher infectious titres of WHO-recommended egg-derived A/Sydney/5/2021 (H1N1)pdm09-like and B/Austria/1359417/2021 vaccine viruses, with titres approaching those obtained in embryonated chicken eggs and exceeding Vero cell yields by 0.9-1.7 log₁₀ EID₅₀/ml. No replication advantage was observed for the egg-derived A/Croatia/10136RV/2023 (H3N2) vaccine virus, carrying the egg-adaptive HA G53D substitution, or for the egg-derived A/duck/Vietnam/NCVD-1584/2012 (H5N1) vaccine strain. However, the A/Darwin/9/2021-like Vero-derived primary isolate A/Austria/1516645/2022 (H3N2), lacking G53D, reached infectious titres up to 3.0 log₁₀ TCID₅₀/ml higher than in Vero and 2.3 log₁₀ TCID₅₀/ml higher than in MDCK cells. H1N1 UniFluVec-based influenza virus vectors also replicated efficiently in AEX-1 cells. Transcriptomic analysis revealed changes in genes involved in proton transport, vesicular acidification, and intracellular pH regulation. AEX-1 remained genetically stable after prolonged passaging and showed no evidence of increased tumorigenicity in vitro or in vivo.
Enhanced intracellular acidification may contribute to improved influenza virus replication in AEX-1 cells, suggesting that modulation of endosomal acidification may provide a rational strategy for developing improved cell substrates for influenza vaccine production.

PMID:
42893625
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.